Market news

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug A...

The penalty comes after a man suffered life-changing injuries when a crate fell on him.

Smith & Nephew (SNN) accepted $250 million of its 2.032% senior notes due 2030 in a cash tender offe

Smith+Nephew announces results of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, GB / ACCESS Newswire / September 16, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the results of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to

Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, UK / ACCESS Newswire / September 15, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the pricing of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to

Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, UK / ACCESS Newswire / September 8, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announces today an offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to U.

Panmure Liberum has cut its target price for Smith & Nephew PLC (LSE:SN), the medical devices maker, to 1120p from 1250p, while maintaining its 'hold' rating. The broker said it still struggled to make a credible investment case after a disappointing second quarter and the departure of...

Smith & Nephew (SNN) has an average rating of hold and mean price target of $31.77, according to ana

UBS has cut its price target on Smith & Nephew PLC (LSE:SN) to 1,120p from 1,300p, warning that even the medical device group's recently reduced guidance for this year remains at risk. The neutral rating is unchanged, with the new target implying about 3.5% upside from Monday's close of...

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins Baxter after the company sold two business units.

Smith & Nephew stock is downgraded to 'Hold' amid weak orthopedics, a guidance cut, and exec turnover. Here's what you need to know about SNN.

John Rogers has stepped down from the board and will leave next month after the introduction of a controversial pay policy for US-based executives

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Smith & Nephew PLC (LSE:SN) shares fell 3.5% to 1,071.84p early on Wednesday after finance chief John Rogers stepped down from the medical technology company's board with immediate effect. Rogers will officially leave his position as chief financial officer on 30 September as he takes up...

Smith & Nephew PLC (LSE:SN) share prices weakened around 3% after the company announced that chief financial officer John Rogers will leave the company at the end of September. The medical technology group's shares fell as low as 3.5% in early London trading to around 1,072p against...

SNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.

Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and Imperial College London have launched a five-year partnership to deliver breakthrough research and innovation for robotic surgery for musculoskeletal conditions. The first-in-kind partnership will bring together a globally renowned academic laboratory with e

Tipranks Press Release.

GlobeNewswire Press Release.

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Canton, Ohio—As thousands of football fans descend on Canton for the 2026 Pro Football Hall of Fame Enshrinement Week, Smith+Nephew, the Global me...

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Nath addresses Orthopaedics gaps and skin substitute headwinds.

The UK medical devices company has lost market share in America after supply disruptions

Smith & Nephew (SNN) reported fiscal Q2 revenue Tuesday of $1.6 billion, up from $1.55 billion a yea

Smith & Nephew (LSE:SN. ) has lowered its full-year revenue growth outlook after reporting a weaker-than-expected second quarter, with lower U.

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.